Summary

Global E-Prescribing Market has valued at USD 2.52 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.30% through 2029. In the ever-evolving landscape of healthcare, technological advancements continue to shape the way medical professionals deliver patient care. One such innovation that has gained significant traction in recent years is electronic prescribing, or e-prescribing. The Global E-Prescribing Market has been experiencing substantial growth as healthcare providers, pharmacies, and patients increasingly recognize its benefits. Electronic prescribing, commonly referred to as e-prescribing, is a digital solution that allows healthcare providers to generate and transmit prescription orders electronically to pharmacies. It replaces traditional handwritten or printed paper prescriptions, offering a more efficient and accurate method for medication management. E-prescribing encompasses various components, including the creation of prescriptions, real-time medication history access, medication alerts, and connectivity to electronic health records (EHRs).
E-prescribing reduces the potential for medication errors, such as illegible handwriting and incorrect dosages, resulting in improved patient safety. It streamlines the prescription process by eliminating the need for manual entry and reducing administrative burdens on healthcare professionals. E-prescribing systems often come with features that enable patients to receive medication reminders and access relevant information, contributing to improved adherence. E-prescribing solutions are increasingly integrated with electronic health records, providing comprehensive patient information at the point of care. Governments and regulatory bodies in many countries have encouraged the adoption of e-prescribing to enhance healthcare quality and reduce costs.
Key Market Drivers
Increasing Government Initiatives and Regulations is Driving the Global E-Prescribing Market
The global healthcare landscape is evolving at a rapid pace, with technological advancements playing a pivotal role in transforming the way medical services are delivered. One such technological revolution in healthcare is the adoption of electronic prescribing, commonly known as e-prescribing. E-prescribing is a digital solution that streamlines the prescription process, ensuring accuracy, efficiency, and patient safety. In recent years, the global e-prescribing market has witnessed substantial growth, largely fueled by increasing government initiatives and regulations aimed at enhancing healthcare quality and reducing medication errors.
The growth of the global e-prescribing market can be primarily attributed to the increasing support and guidance from governments and regulatory bodies. These initiatives aim to address various issues within the healthcare system, such as patient safety, healthcare quality, and cost containment. In the United States, the Centers for Medicare and Medicaid Services (CMS) introduced the Electronic Health Record (EHR) Incentive Program, commonly referred to as "Meaningful Use." This program provides financial incentives to healthcare providers who adopt and demonstrate the meaningful use of EHRs, including e-prescribing. In the United States, the DEA implemented regulations in 2010 allowing for the electronic prescribing of controlled substances, further promoting the adoption of e-prescribing systems. Various governments around the world have launched healthcare information technology (IT) initiatives to encourage the implementation of EHRs and e-prescribing systems, often providing financial incentives to healthcare organizations that comply. Regulatory bodies like The Joint Commission in the United States and similar organizations globally have recognized e-prescribing as a means to enhance patient safety, thereby encouraging its adoption by healthcare facilities. Governments have played a role in setting standards and promoting interoperability between healthcare systems, ensuring seamless data exchange between different stakeholders in the healthcare ecosystem.
Increased Efficiency and Convenience is Driving the Global E-Prescribing Market
One of the primary drivers of the global e-prescribing market is the significant improvement in efficiency it offers. Healthcare providers, including physicians, nurse practitioners, and other prescribers, can easily access patients' medical histories, insurance information, and preferred pharmacies. This information allows them to make informed decisions quickly and prescribe the most suitable medication, eliminating errors and ensuring patient safety. Moreover, e-prescribing enables real-time communication with pharmacies, reducing waiting times for patients and enhancing overall healthcare delivery. E-prescribing plays a vital role in enhancing patient safety by reducing medication errors. The digitization of prescriptions minimizes the chances of misinterpretation or illegible handwriting, which can lead to adverse drug events. With e-prescribing, drug-drug interaction alerts and dosage recommendations are readily available, assisting prescribers in making informed decisions. This leads to a safer and more effective medication management process for patients.
The adoption of e-prescribing systems has streamlined healthcare workflows for both providers and pharmacies. Prescribers can quickly and accurately send prescriptions to pharmacies, eliminating the need for patients to carry physical prescriptions. Pharmacists, in turn, can efficiently process electronic prescriptions, reducing wait times and enhancing customer satisfaction. These streamlined processes have a significant impact on patient care and overall healthcare system efficiency.
Key Market Challenges
Implementation Barriers
One of the primary challenges faced by the e-prescribing market is the resistance to implementation. Transitioning from paper-based prescription systems to electronic prescribing requires significant investment in both technology and training. Healthcare providers, especially in smaller practices and rural areas, may find it challenging to adapt to new systems, which can lead to slower adoption rates. Moreover, interoperability issues between various electronic health record (EHR) systems and pharmacy software can hinder seamless information exchange. Ensuring that these systems can communicate effectively is crucial for the success of e-prescribing.
Data Privacy and Security
The healthcare industry, including e-prescribing, deals with sensitive patient information. The need to protect patient data from security breaches and unauthorized access is paramount. Healthcare providers and technology companies must invest in robust cybersecurity measures to safeguard electronic health records and prescription data. Compliance with stringent data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, adds complexity to the e-prescribing landscape.
Medication Errors and Decision Support
While e-prescribing can reduce some medication errors associated with illegible handwriting, it introduces new challenges. Decision support tools embedded in e-prescribing systems may generate alerts and suggestions for healthcare providers, but these alerts can sometimes be overwhelming and lead to alert fatigue. Striking the right balance between providing useful guidance and avoiding excessive interruptions in the workflow of healthcare professionals is a significant challenge.
Prescription Drug Abuse
The electronic nature of e-prescribing can pose challenges in controlling prescription drug abuse. Illicit drug seekers may manipulate the system to obtain controlled substances. Ensuring that e-prescribing systems have robust features to detect and prevent prescription fraud is essential for addressing this issue.
Internet Access and Infrastructure
Access to high-speed internet and reliable infrastructure can be a significant hurdle in some regions, particularly in rural and underserved areas. E-prescribing relies on a stable internet connection for real-time transmission of prescriptions, patient information, and pharmacy communication. The lack of internet access in certain areas can limit the reach and effectiveness of e-prescribing.
Cost and Return on Investment
Investing in e-prescribing technology, software, and training can be costly for healthcare providers, especially for smaller practices and healthcare facilities with limited budgets. Demonstrating a clear return on investment (ROI) in terms of improved patient care, reduced errors, and cost savings can be challenging, and some healthcare organizations may be hesitant to make the upfront investment.
Regulatory and Legal Challenges
The e-prescribing landscape is subject to a complex web of regulations and legal requirements. Different countries and regions have their own rules and standards for e-prescribing, making it difficult for technology providers to develop standardized solutions that work universally. Navigating these regulatory frameworks while maintaining compliance is a continuous challenge for the e-prescribing industry.
Key Market Trends
Technological Advancements
The global healthcare industry is undergoing a profound transformation, largely driven by the increasing adoption of advanced technologies. One of the significant technological advancements revolutionizing healthcare is e-prescribing, a practice that allows healthcare providers to electronically generate and send prescriptions to pharmacies. E-prescribing has come a long way since its inception in the early 2000s. What started as a convenient alternative to handwritten prescriptions has evolved into a sophisticated system that leverages the power of technology to improve the entire medication management process. In the early days, e-prescribing systems were relatively basic, primarily focused on eliminating errors caused by illegible handwriting. However, today's e-prescribing solutions are significantly more advanced and provide a multitude of benefits for both healthcare providers and patients.
One of the key technological advancements driving the growth of the e-prescribing market is improved interoperability. Modern e-prescribing systems can seamlessly integrate with electronic health records (EHR) and other healthcare information systems. This integration allows healthcare providers to access a patient's complete medical history, drug allergies, and medication records, ensuring that prescriptions are safer and more accurate. Sophisticated decision support tools integrated into e-prescribing systems assist healthcare providers in making more informed decisions. These tools provide real-time drug interaction alerts, dosage recommendations, and generic drug alternatives, thereby enhancing patient safety and helping to reduce medication errors.
The advent of mobile and cloud-based e-prescribing solutions has made it easier for healthcare providers to create and transmit electronic prescriptions from virtually anywhere. This flexibility not only improves efficiency but also allows for more convenient and timely patient care. The rise of telemedicine has further fueled the adoption of e-prescribing. Telehealth consultations often culminate in the need for a prescription, which can be efficiently generated and transmitted electronically through the same platform, enhancing the patient experience. E-prescribing systems have significantly improved in terms of security features. Encryptions, user authentication, and audit trails ensure that patient data remains secure and compliant with privacy regulations. This reassures both healthcare providers and patients.
Segmental Insights
Product Insights
Based on the category of product, Solutions emerged as the dominant player in the global market for E-Prescribing in 2023. E-prescribing significantly reduces the chances of prescription errors. The ability to access a patient's complete medical history and drug allergies in real-time allows healthcare providers to make informed decisions, leading to safer patient care. In addition, it minimizes the risk of misinterpretation of handwritten prescriptions. E-prescribing systems offer automated reminders and alerts for patients, ensuring that they adhere to their prescribed medication regimens. This feature contributes to better health outcomes and reduces the likelihood of hospital readmissions.
Application Insights
The Sports Medicine segment is projected to experience rapid growth during the forecast period. Sports medicine is a specialized branch of healthcare that focuses on the prevention, diagnosis, treatment, and rehabilitation of injuries and conditions related to physical activity and sports. It encompasses a wide range of medical disciplines, including orthopedics, physical therapy, sports science, nutrition, and more. As the popularity of sports and physical fitness continues to rise, the demand for sports medicine services has grown significantly.
Athletes frequently encounter injuries that require specialized treatments and medications. E-prescribing simplifies the process of prescribing medications and rehabilitation equipment, allowing sports medicine professionals to quickly and accurately provide the necessary care. This not only accelerates the recovery process but also reduces the risk of medication errors. In the high-pressure world of sports, it is crucial to ensure that athletes receive the right medication at the right time. E-prescribing systems come with safety features, such as drug interaction checks and allergy alerts, that help sports medicine practitioners avoid potentially dangerous medication combinations. E-prescribing promotes better communication between sports medicine practitioners, athletes, and pharmacists. When a prescription is electronically transmitted, the pharmacist can easily access detailed information, enabling them to prepare the medication and equipment more efficiently. This seamless collaboration ensures that athletes receive the most effective treatment.
Regional Insights
North America emerged as the dominant player in the global E-Prescribing market in 2023, holding the largest market share in terms of value One of the primary reasons for North America's prominence in the e-prescribing market is the robust regulatory support and framework in place. The United States, in particular, has played a pivotal role in shaping e-prescribing guidelines and standards. The Drug Enforcement Administration (DEA) established the Electronic Prescriptions for Controlled Substances (EPCS) rule, allowing the electronic prescribing of controlled substances, which was a significant milestone in advancing e-prescribing technology. Additionally, the Health Information Technology for Economic and Clinical Health (HITECH) Act incentivized healthcare providers to adopt electronic health records (EHR) systems, further driving e-prescribing adoption. E-prescribing systems significantly enhance patient safety by reducing medication errors, which are a significant concern in healthcare. These systems allow healthcare providers to access patients' medication histories, check for potential drug interactions, and provide accurate dosage information, leading to a decrease in adverse drug events. Patients can also receive their prescriptions directly at the pharmacy, eliminating the need for paper prescriptions that can be lost or misinterpreted. This emphasis on patient safety has been a driving factor behind the adoption of e-prescribing in North America.
Key Market Players
• Cerner Corporation (Oracle)
• Allscripts Healthcare, LLC
• Epic Systems Corporation
• Athenahealth
• NXGN Management, LLC
• McKesson Corporation
• Surescripts
• Change Healthcare
• Practice Fusion, Inc.
• Networking Technology, Inc. (RXNT)

Report Scope:
In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• E-Prescribing Market, By Product:
o Solutions
o Services
• E-Prescribing Market, By Specialties:
o Oncology
o Sports Medicine
o Neurology
o Cardiology
o Others
• E-Prescribing Market, By Delivery Mode:
o Web/Cloud Based
o On Premise
• E-Prescribing Market, By Substances:
o Controlled Substances
o Non-controlled Substances
• E-Prescribing Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 France
 United Kingdom
 Italy
 Germany
 Spain
o Asia-Pacific
 China
 India
 Japan
 Australia
 South Korea
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the E-Prescribing Market.
Available Customizations:
Global E-Prescribing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Product (Solutions (Integrated Solutions, Standalone Solutions), Services(Support, Implementation, Training, Network)
4.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
4.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
4.2.4. By Substances (Controlled Substances, Non-controlled Substances)
4.2.5. By Region
4.2.6. By Company (2023)
4.3. Market Map
4.3.1. By Product
4.3.2. By Specialties
4.3.3. By Delivery Mode
4.3.4. By Substances
4.3.5. By Region
5. Asia Pacific E-Prescribing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Specialties
5.2.3. By Delivery Mode
5.2.4. By Substances
5.2.5. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China E-Prescribing Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Product
5.3.1.2.2. By Specialties
5.3.1.2.3. By Delivery Mode
5.3.1.2.4. By Substances
5.3.2. India E-Prescribing Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Product
5.3.2.2.2. By Specialties
5.3.2.2.3. By Delivery Mode
5.3.2.2.4. By Substances
5.3.3. Australia E-Prescribing Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Product
5.3.3.2.2. By Specialties
5.3.3.2.3. By Delivery Mode
5.3.3.2.4. By Substances
5.3.4. Japan E-Prescribing Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Product
5.3.4.2.2. By Specialties
5.3.4.2.3. By Delivery Mode
5.3.4.2.4. By Substances
5.3.5. South Korea E-Prescribing Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Product
5.3.5.2.2. By Specialties
5.3.5.2.3. By Delivery Mode
5.3.5.2.4. By Substances
6. Europe E-Prescribing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Specialties
6.2.3. By Delivery Mode
6.2.4. By Substances
6.2.5. By Country
6.3. Europe: Country Analysis
6.3.1. France E-Prescribing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Specialties
6.3.1.2.3. By Delivery Mode
6.3.1.2.4. By Substances
6.3.2. Germany E-Prescribing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Specialties
6.3.2.2.3. By Delivery Mode
6.3.2.2.4. By Substances
6.3.3. Spain E-Prescribing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Specialties
6.3.3.2.3. By Delivery Mode
6.3.3.2.4. By Substances
6.3.4. Italy E-Prescribing Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product
6.3.4.2.2. By Specialties
6.3.4.2.3. By Delivery Mode
6.3.4.2.4. By Substances
6.3.5. United Kingdom E-Prescribing Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product
6.3.5.2.2. By Specialties
6.3.5.2.3. By Delivery Mode
6.3.5.2.4. By Substances
7. North America E-Prescribing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Specialties
7.2.3. By Delivery Mode
7.2.4. By Substances
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States E-Prescribing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Specialties
7.3.1.2.3. By Delivery Mode
7.3.1.2.4. By Substances
7.3.2. Mexico E-Prescribing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Specialties
7.3.2.2.3. By Delivery Mode
7.3.2.2.4. By Substances
7.3.3. Canada E-Prescribing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Specialties
7.3.3.2.3. By Delivery Mode
7.3.3.2.4. By Substances
8. South America E-Prescribing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Specialties
8.2.3. By Delivery Mode
8.2.4. By Substances
8.2.5. By Country
8.3. South America: Country Analysis
8.3.1. Brazil E-Prescribing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Specialties
8.3.1.2.3. By Delivery Mode
8.3.1.2.4. By Substances
8.3.2. Argentina E-Prescribing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Specialties
8.3.2.2.3. By Delivery Mode
8.3.2.2.4. By Substances
8.3.3. Colombia E-Prescribing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Specialties
8.3.3.2.3. By Delivery Mode
8.3.3.2.4. By Substances
9. Middle East and Africa E-Prescribing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Specialties
9.2.3. By Delivery Mode
9.2.4. By Substances
9.2.5. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa E-Prescribing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Specialties
9.3.1.2.3. By Delivery Mode
9.3.1.2.4. By Substances
9.3.2. Saudi Arabia E-Prescribing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Specialties
9.3.2.2.3. By Delivery Mode
9.3.2.2.4. By Substances
9.3.3. UAE E-Prescribing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Specialties
9.3.3.2.3. By Delivery Mode
9.3.3.2.4. By Substances
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global E-Prescribing Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. Cerner Corporation (Oracle)
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Allscripts Healthcare, LLC
14.3. Epic Systems Corporation
14.4. Athenahealth
14.5. NXGN Management, LLC
14.6. McKesson Corporation
14.7. Surescripts
14.8. Change Healthcare
14.9. Practice Fusion, Inc.
14.10.Networking Technology, Inc. (RXNT)
15. Strategic Recommendations
16. About Us & Disclaimer